Frontotemporal dementia: A review for primary care physicians

American Family Physician

Volumn 82, Issue 11, 2010, Pages 1372-1377

  Cardarelli, Roberto ^a   Kertesz, Andrew ^b   Knebl, Janice A ^a  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE INHIBITOR; GALANTAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT; SEROTONIN UPTAKE INHIBITOR; TAR DNA BINDING PROTEIN; TAU PROTEIN;

ALZHEIMER DISEASE; BEHAVIOR THERAPY; BLUNTED AFFECT; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; FRONTAL VARIANT FRONTOTEMPORAL DEMENTIA; FRONTOTEMPORAL DEMENTIA; GENERAL PRACTITIONER; HUMAN; INTERDISCIPLINARY COMMUNICATION; LEARNING DISORDER; NEUROIMAGING; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT EDUCATION; PATIENT IDENTIFICATION; PHYSICIAN ATTITUDE; PICK PRESENILE DEMENTIA; PRIMARY MEDICAL CARE; PROGNOSIS; PROGRESSIVE NONFLUENT APHASIA; REVIEW; SCREENING TEST; SEMANTIC DEMENTIA; SOCIAL DISABILITY; SURVIVAL RATE; THOUGHT DISORDER; ATROPHY; CLINICAL COMPETENCE; FRONTAL LOBE; NEUROPSYCHOLOGICAL TEST; PATHOLOGY; TEMPORAL LOBE;

ATROPHY; CLINICAL COMPETENCE; DIAGNOSIS, DIFFERENTIAL; FRONTAL LOBE; FRONTOTEMPORAL DEMENTIA; HUMANS; MAGNETIC RESONANCE IMAGING; NEUROPSYCHOLOGICAL TESTS; PHYSICIANS, PRIMARY CARE; TEMPORAL LOBE;

EID: 79951963656     PISSN: 0002838X     EISSN: 0002838X     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Pasquier F, Delacourte A. Non-Alzheimer degenerative dementias. Curr Opin Neurol. 1998;11(5):417-427.
2. Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups. J Neurol Neurosurg Psychiatry. 1994;57(4):416-418.
3. Ratnavalli E, Brayne C, Dawson K, Hodges JR. The prevalence of frontotemporal dementia. Neurology. 2002;58(11):1615-1621.
4. Kertesz A. Pick complex: an integrative approach to frontotemporal dementia: primary progressive aphasia, corticobasal degeneration, and progressive supranuclear palsy. Neurologist. 2003;9(6):311-317.
5. Josephs KA. Frontotemporal dementia and related disorders: deciphering the enigma. Ann Neurol. 2008;64(1):4-14.
6. Mendez MF, Perryman KM. Neuropsychiatric features of frontotemporal dementia: evaluation of consensus criteria and review. J Neuropsychiatry Clin Neurosci. 2002;14(4):424-429.
7. Gregory CA, Hodges JR. Clinical features of frontal lobe dementia in comparison to Alzheimer's disease. J Neural Transm Suppl. 1996;47:103-123.
8. Passant U, Elfgren C, Englund E, Gustafson L. Psychiatric symptoms and their psychosocial consequences in frontotemporal dementia. Alzheimer Dis Assoc Disord. 2005;19(suppl 1):S15-S18.
9. Mendez MF, Shapira JS, McMurtray A, Licht E, Miller BL. Accuracy of the clinical evaluation for frontotemporal dementia. Arch Neurol. 2007;64(6):830-835.
10. Wittenberg D, Possin KL, Rascovsky K, Rankin KP, Miller BL, Kramer JH. The early neuropsychological and behavioral characteristics of frontotemporal dementia. Neuropsychol Rev. 2008;18(1):91-102.
11. Amador-Ortiz C, Lin WL, Ahmed Z, et al. TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease. Ann Neurol. 2007;61(5):435-445.
12. Cairns NJ, Bigio EH, Mackenzie IR, et al. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol. 2007;114(1):5-22.
13. Neumann M, Kwong LK, Sampathu DM, Trojanowski JQ, Lee VM. TDP-43 proteinopathy in frontotemporal lobar degeneration and amyotrophic lateral sclerosis: protein misfolding diseases without amyloidosis. Arch Neurol. 2007;64(10):1388-1394.
14. Sikkink S, Rollinson S, Pickering-Brown SM. The genetics of frontotemporal lobar degeneration. Curr Opin Neurol. 2007;20(6):693-698.
15. Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998;51(6):1546-1554.
16. Mathuranath PS, Nestor PJ, Berrios GE, Rakowicz W, Hodges JR. A brief cognitive test battery to differentiate Alzheimer's disease and frontotemporal dementia. Neurology. 2000;55(11):1613-1620.
17. Kertesz A, Nadkarni N, Davidson W, Thomas AW. The Frontal Behavioral Inventory in the differential diagnosis of frontotemporal dementia. J Int Neuropsychol Soc. 2000;6(4):460-468.
18. Mendez MF, Lauterbach EC, Sampson SM; ANPA Committee on Research. An evidence-based review of the psychopathology of frontotemporal dementia: a report of the ANPA Committee on Research. J Neuropsychiatry Clin Neurosci. 2008;20(2):130-149.
19. Galante E, Muggia S, Spinnler H, Zuffi M. Degenerative dementia of the frontal type. Clinical evidence from 9 cases. Dement Geriatr Cogn Disord. 1999;10(1):28-39.
20. Lindau M, Almkvist O, Kushi J, et al. First symptoms-frontotemporal dementia versus Alzheimer's disease. Dement Geriatr Cogn Disord. 2000;11(5):286-293.
21. Rankin KP, Rosen HJ, Kramer JH, et al. Right and left medial orbitofrontal volumes show an opposite relationship to agreeableness in FTD. Dement Geriatr Cogn Disord. 2004;17(4):328-332.
22. Diehl-Schmid J, Pohl C, Perneczky R, Förstl H, Kurz A. Behavioral disturbances in the course of frontotemporal dementia. Dement Geriatr Cogn Disord. 2006;22(4):352-357.
23. Mendez MF, Shapira JS, Woods RJ, Licht EA, Saul RE. Psychotic symptoms in frontotemporal dementia: prevalence and review. Dement Geriatr Cogn Disord. 2008;25(3):206-211.
24. Bolla LR, Filley CM, Palmer RM. Dementia DDx. Office diagnosis of the four major types of dementia. Geriatrics. 2000;55(1):34-37, 41-42, 45-46.
25. Padovani A, Costanzi C, Gilberti N, Borroni B. Parkinson's disease and dementia. Neurol Sci. 2006;27(suppl 1):S40-S43.
26. Chow TW, Mendez MF. Goals in symptomatic pharmacologic management of frontotemporal lobar degeneration. Am J Alzheimers Dis Other Demen. 2002;17(5):267-272.
27. Swartz JR, Miller BL, Lesser IM, Darby AL. Frontotemporal dementia: treatment response to serotonin selective reuptake inhibitors [published correction appears in J Clin Psychiatry. 1997;58(6):275]. J Clin Psychiatry. 1997;58(5):212-216.
28. Chow TW. Frontotemporal dementias: clinical features and management. Semin Clin Neuropsychiatry. 2003;8(1):58-70.
29. Huey ED, Putnam KT, Grafman J. A systematic review of neurotransmitter deficits and treatments in frontotemporal dementia. Neurology. 2006;66(1):17-22.
30. Kertesz A, Morlog D, Light M, et al. Galantamine in frontotemporal dementia and primary progressive aphasia. Dement Geriatr Cogn Disord. 2008;25(2):178-185.
31. Roberson ED, Hesse JH, Rose KD, et al. Frontotemporal dementia progresses to death faster than Alzheimer disease. Neurology. 2005;65(5):719-725.